208 related articles for article (PubMed ID: 758030)
1. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
Trznadel K; Kidawa Z; Walasek L; Lutz W
Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
[No Abstract] [Full Text] [Related]
2. Uremic middle molecules exist and are biologically active.
Bergström J; Fürst P; Zimmerman L
Clin Nephrol; 1979 May; 11(5):229-38. PubMed ID: 455821
[No Abstract] [Full Text] [Related]
3. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
Splendiani G; Albano V; Tancredi M; Daniele M; Pignatelli F
Biomater Artif Cells Artif Organs; 1987; 15(1):175-81. PubMed ID: 3449135
[TBL] [Abstract][Full Text] [Related]
4. [Depurative efficiency of intermediate and large molecules with different hemodialysis modalities].
Maduell F
Nefrologia; 2005; 25 Suppl 2():15-8. PubMed ID: 16050396
[TBL] [Abstract][Full Text] [Related]
5. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
Popławski A; Myśliwiec M; Soszka J
Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies on the effect of hemoperfusion and hemodialysis on the elimination of some uremic toxins.
Trznadel K; Walasek L; Kidawa Z; Lutz W
Clin Nephrol; 1978 Dec; 10(6):229-31. PubMed ID: 729215
[TBL] [Abstract][Full Text] [Related]
7. [Examination of lymphokines in patients with hemodialysis (author's transl)].
Löcsey L; Kálmán K; Hauck M; Kakuk G
Allerg Immunol (Leipz); 1979; 25(3):211-7. PubMed ID: 162030
[TBL] [Abstract][Full Text] [Related]
8. Middle molecules in hepatic coma and uremia.
Chang TM; Lister C
Artif Organs; 1981; 4 Suppl():169-72. PubMed ID: 7295086
[No Abstract] [Full Text] [Related]
9. Rationale for combined hemoperfusion/hemodialysis in uremia.
Winchester JF; Ronco C; Brady JA; Brendolan A; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Clemmer J; Polaschegg HD; Muller TE; La Greca G; Levin NW
Contrib Nephrol; 2001; (133):174-9. PubMed ID: 11477750
[No Abstract] [Full Text] [Related]
10. Serum middle molecules in uremia.
Buzio C; Manari A; Calderini C; Montagna G; Migone L
Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
[No Abstract] [Full Text] [Related]
11. The use of hemoperfusion as an adjunct to hemodialysis.
Trafford A; Ireland R; Evans R
Artif Organs; 1979 Aug; 3(3):249-52. PubMed ID: 533415
[TBL] [Abstract][Full Text] [Related]
12. A purification method by uncoated charcoal.
Cerulli N; Politi L; D'Angelo AR; Scandurra R
Adv Exp Med Biol; 1987; 223():193-6. PubMed ID: 3447435
[No Abstract] [Full Text] [Related]
13. [Middle molecules and the problem of endogenous intoxication in critical states of various etiologies].
Vladyka AS; Levitskiĭ ER; Poddubnaia LP; Gabriélian NI
Anesteziol Reanimatol; 1987; (2):37-42. PubMed ID: 3300433
[No Abstract] [Full Text] [Related]
14. [Effect of hemoperfusion on various blood coagulation and fibrinolysis factors in chronic uremia].
Lewicki R; Trznadel K; Luciak M; Kidawa Z
Pol Tyg Lek; 1981 Aug; 36(35):1325-7. PubMed ID: 7329845
[No Abstract] [Full Text] [Related]
15. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
Popławski A; Myśliwiec M
Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
[No Abstract] [Full Text] [Related]
16. Action of middle molecules from chronic renal insufficiency treated by hemodialysis on mitochondrial respiration.
Rinaudo JB; Gallice P; Crevat A; Saingra S; Murisasco A
Biomedicine; 1979 Oct; 30(4):215-8. PubMed ID: 534675
[TBL] [Abstract][Full Text] [Related]
17. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
Sarnatskaya VV; Yushko LA; Sakhno LA; Nikolaev VG; Nikolaev AV; Grinenko DV; Mikhalovsky SV
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(3):287-308. PubMed ID: 17573628
[TBL] [Abstract][Full Text] [Related]
18. Continuous measurement of DTPA-clearance in extracorporeal detoxification circuits.
Falkenhagen D; Ahrenholz P; Roy T; Esther G; Kiencke H; Klinkmann H
Artif Organs; 1981; 4 Suppl():166-8. PubMed ID: 7295085
[TBL] [Abstract][Full Text] [Related]
19. Middle molecules in uraemia.
Fürst P; Asaba M; Gordon A; Zimmerman L; Bergström J
Proc Eur Dial Transplant Assoc; 1975; 11():417-26. PubMed ID: 1105558
[No Abstract] [Full Text] [Related]
20. Concentration of plasma middle molecular weight substances and clinical condition of patients undergoing short-time regular dialysis treatment.
Válek A; Dzúrik R; Spustová V; Válková D
Artif Organs; 1981; 4 Suppl():173-6. PubMed ID: 7295088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
